Literature DB >> 24503498

A qualitative study of underutilization of the AIDS drug assistance program.

Kristin M Olson, Noah C Godwin, Sara Anne Wilkins, Michael J Mugavero, Linda D Moneyham, Larry Z Slater, James L Raper.   

Abstract

In our previous work, we demonstrated underutilization of the AIDS Drug Assistance Program (ADAP) at an HIV clinic in Alabama. In order to understand barriers and facilitators to utilization of ADAP, we conducted focus groups of ADAP enrollees. Focus groups were stratified by sex, race, and historical medication possession ratio as a measure of program utilization. We grouped factors according to the social-ecological model. We found that multiple levels of influence, including patient and clinic-related factors, influenced utilization of antiretroviral medications. Patients introduced issues that illustrated high-priority needs for ADAP policy and implementation, suggesting that in order to improve ADAP utilization, the following issues must be addressed: patient transportation, ADAP medication refill schedules and procedures, mailing of medications, and the ADAP recertification process. These findings can inform a strategy of approaches to improve ADAP utilization, which may have widespread implications for ADAP programs across the United States.
Copyright © 2014 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIDS Drug Assistance Program; policy; qualitative; social-ecological model; utilization

Mesh:

Substances:

Year:  2014        PMID: 24503498      PMCID: PMC4267675          DOI: 10.1016/j.jana.2013.11.003

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  22 in total

1.  Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences.

Authors:  S Reif; C E Golin; S R Smith
Journal:  AIDS Care       Date:  2005-07

2.  Micro-social structural approaches to HIV prevention: a social ecological perspective.

Authors:  C A Latkin; A R Knowlton
Journal:  AIDS Care       Date:  2005-06

3.  Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

Authors:  Terry R Barclay; Charles H Hinkin; Steven A Castellon; Karen I Mason; Matthew J Reinhard; Sarah D Marion; Andrew J Levine; Ramani S Durvasula
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

Review 4.  Adherence in antiretroviral therapy: a review of qualitative studies.

Authors:  Sigrid C J M Vervoort; Jan C C Borleffs; Andy I M Hoepelman; Mieke H F Grypdonck
Journal:  AIDS       Date:  2007-01-30       Impact factor: 4.177

5.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

6.  Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS.

Authors:  Jeffrey S Gonzalez; Frank J Penedo; Michael H Antoni; Ron E Durán; Shvawn McPherson-Baker; Gail Ironson; Maria Isabel Fernandez; Nancy G Klimas; Mary Ann Fletcher; Neil Schneiderman
Journal:  Health Psychol       Date:  2004-07       Impact factor: 4.267

7.  Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States.

Authors:  Medha Vyavaharkar; Linda Moneyham; Abbas Tavakoli; Kenneth D Phillips; Carolyn Murdaugh; Kirby Jackson; Gene Meding
Journal:  AIDS Patient Care STDS       Date:  2007-09       Impact factor: 5.078

8.  Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.

Authors:  Nancy R Reynolds; Marcia A Testa; Linda G Marc; Margaret A Chesney; Judith L Neidig; Scott R Smith; Stefano Vella; Gregory K Robbins
Journal:  AIDS Behav       Date:  2004-06

9.  AIDS Drug Assistance Programs: managers confront uncertainty and need to adapt as the Affordable Care Act kicks in.

Authors:  Erika G Martin; Terence Meehan; Bruce R Schackman
Journal:  Health Aff (Millwood)       Date:  2013-06       Impact factor: 6.301

Review 10.  HIV/AIDS: AIDS Drug Assistance Programs in the era of routine HIV testing.

Authors:  Ingrid V Bassett; Claire Farel; Emily D Szmuilowicz; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

View more
  3 in total

1.  Financial Barriers and Lapses in Treatment and Care of HIV-Infected Adults in a Southern State in the United States.

Authors:  David A Wohl; Rita K Kuwahara; Kamran Javadi; Christine Kirby; David L Rosen; Sonia Napravnik; Claire Farel
Journal:  AIDS Patient Care STDS       Date:  2017-10-17       Impact factor: 5.078

2.  Characterization of the Population Affected by the 6-Month Recertification Criterion of the Ryan White HIV/AIDS Program's AIDS Drug Assistance Program in Washington State, 2017-2019.

Authors:  Steven Erly; Christine M Khosropour; Anjum Hajat; Monisha Sharma; Jen Reuer; Martha Grimm; Kelse Kwaiser; Julia C Dombrowski
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

3.  Practical and Ethical Concerns in Implementing Enhanced Surveillance Methods to Improve Continuity of HIV Care: Qualitative Expert Stakeholder Study.

Authors:  Mara Buchbinder; Colleen Blue; Stuart Rennie; Eric Juengst; Lauren Brinkley-Rubinstein; David L Rosen
Journal:  JMIR Public Health Surveill       Date:  2020-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.